Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Psychotropic drugs can cause hair loss or excessive hair growth.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Imatinib can cause hair loss due to lichen planopilaris.

Escitalopram might effectively treat delusions of parasitosis and possibly Morgellons disease, with psychological factors being important to consider.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ferulic acid can reduce seizures and depression-like behaviors in catamenial epilepsy by balancing hormones and brain enzyme activity.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Monilethrix is not caused by a metabolic defect.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.